Acumen Pharmaceuticals Inc — Cash Flow (NASDAQ:ABOS) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -17.96 M-35.15 M-43.06 M-86.22 M-115.54 M -115.54 M Cash from investing activities -104.12 M39.19 M-171.67 M48.03 M133.93 M 133.93 M Cash from financing activities 200.47 M3.91 M151.75 M6.93 M-34 K -34 K Free cash flow -18 M-35.31 M-43.09 M-86.23 M-115.63 M -115.63 M

Haberler

Stifel, Acumen Pharmaceuticals için al tavsiyesini korudu

Acumen Pharmaceuticals 2025 4Ç sonuçları stratejik ilerlemeler gösterdi

Cantor Fitzgerald, Acumen Pharmaceuticals hisse önerisini yineledi

Acumen Pharmaceuticals Stifel Forumu’nda: Alzheimer İlacı Hakkında Stratejik Görüşler

Acumen 35,75 milyon dolar topladı, AD ilacı için 2027’yi hedefliyor

Acumen raises $35.75 million, targets 2027 IND filing for AD drug

Acumen Pharma hukuk müdürü 6.813 dolarlık hisse sattı

Acumen Pharma chief legal officer sells $6813 in stock

Acumen Pharma chief legal officer Meisner sells $28k in shares

Acumen Pharma Hukuk Müdürü opsiyon kullanımı sonrası 53 bin dolarlık hisse sattı

Acumen Pharma CLO sells $53k in shares after option exercise

Baker Hughes To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Acumen Pharmaceuticals (NASDAQ:ABOS), Baker Hughes (NASDAQ:BKR)